PFSA News

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025